The global bioconjugation market is projected to grow at an estimated CAGR of close to 13% over the next five years. This growth is fueled by the rising need for targeted therapies, continuous ...

STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a supplier of critical raw materials to the life science industry, is pleased to announce today that it has acquired celares, a leader in the development ...

Officials at Lonza say they will invest in additional bioconjugation capabilities in Visp, Switzerland. The expansion will add two multipurpose 1,200L manufacturing suites and manufacturing-related ...

Bioconjugation capability will complement commercial payload, linker and monoclonal antibodies services The OEB-5 rated suite will accelerate ADC development timelines by enabling both Monoclonal ...

Lonza plans to increase bioconjugation capacity for the production of antibody drug conjugates (ADCs) by 300% with the addition of two commercial-scale bioconjugation suites at its manufacturing site ...

The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply. STAAD, ...

"Joining Gannet BioChem marks an exciting next chapter for our team and our customers,” said Jon McKannan, President of ...

What are the critical factors to bioconjugation success? Explore the workflow and learn how you can get started with quantitative and reproducible bioconjugation. SoluLINK bioconjugation technology ...

Bioconjugation is a critical technique for creating many of the key reagents used in research and commercial applications. This webinar will cover in great detail the major reactions used to form ...

Biomacromolecules, including proteins, enzymes, and antibodies, are the workhorses of living systems and the foundation of breakthrough technologies in medicine, energy, sustainability, and food ...

Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru.